PAH rs121908295: Understanding the p.Arg408Trp Variant

What each genotype means

What is the rs121908295 Variant?

The variant rs121908295, commonly referred to in clinical literature as c.1222C>T or p.Arg408Trp, is a missense mutation located within the PAH gene. This gene is situated on chromosome 12. In a missense mutation, a single nucleotide change in the DNA sequence leads to the substitution of one amino acid for another in the resulting protein. Specifically, this variant causes an arginine to be replaced by a tryptophan at position 408 of the phenylalanine hydroxylase enzyme. This structural alteration is significant because it disrupts the normal function of the enzyme, which is critical for metabolic processes. Because this variant is located in a gene responsible for a well-characterized metabolic pathway, it has been extensively studied in the context of genetic screening and clinical diagnostics for metabolic disorders.

The Role of the PAH Gene

The PAH gene provides the essential instructions for the body to produce an enzyme called phenylalanine hydroxylase. This enzyme acts as a biological catalyst, responsible for converting the amino acid phenylalanine into another amino acid called tyrosine. Phenylalanine is a building block of proteins found in many common foods, including meat, dairy, and certain artificial sweeteners. By working alongside a cofactor called tetrahydrobiopterin (BH4), the phenylalanine hydroxylase enzyme ensures that phenylalanine levels in the body remain within a healthy range. Tyrosine, the product of this conversion, is subsequently used by the body to produce important neurotransmitters and melanin, the pigment responsible for skin and hair color. When the PAH gene contains pathogenic variants, the enzyme may be absent or non-functional, leading to the accumulation of phenylalanine in the blood.

Research and Clinical Associations

Research has established a strong link between the rs121908295 variant and classic phenylketonuria (PKU). PKU is an autosomal recessive disorder, meaning that an individual must inherit two copies of a pathogenic variant—one from each parent—to manifest the condition. The p.Arg408Trp variant is recognized as a major contributor to this condition, with studies indicating it causes a marked loss of enzymatic activity. Because it is a well-documented pathogenic variant, it is frequently included in genetic panels designed to screen for metabolic disorders. While the evidence for its pathogenicity is robust, the clinical presentation of PKU can vary depending on the specific combination of variants an individual carries. It is important to note that this information is for educational purposes and does not constitute a medical diagnosis or clinical advice.

Population Frequency

The frequency of the rs121908295 variant varies significantly across different global populations. It is most notably observed in Central and Eastern European populations, where it has been identified as one of the most prevalent variants associated with PKU. In these regions, the allele frequency is approximately 0.008, though it can be higher in specific clinical cohorts of patients already diagnosed with PKU. Because PKU is an autosomal recessive condition, the prevalence of the disease itself is much lower than the carrier frequency of the variant. Genetic epidemiology studies continue to track these frequencies to better understand the distribution of metabolic traits across diverse ancestral groups. Understanding these patterns helps healthcare providers and researchers identify populations that may benefit most from newborn screening programs and early genetic counseling.

What This Information Means for You

If you have received information regarding your status for the rs121908295 variant, it is important to understand that this is a carrier status marker. Being a carrier means you possess one copy of the variant, which typically does not cause symptoms of PKU, as the other copy of the gene usually provides enough functional enzyme. However, if both parents are carriers, there is a statistical possibility of passing the condition to their children. This information should not be used to make personal health decisions or to diagnose a condition. If you have concerns about your genetic status or family history, the most appropriate step is to consult with a qualified genetic counselor or a medical professional. They can provide context based on your full clinical picture and guide you through the implications of genetic testing results.

Frequently asked questions

Sources & further reading

Related variants in PAH